Sonora Investment Management Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$503K Hold
4,531
0.04% 164
2025
Q2
$502K Sell
4,531
-622
-12% -$66.2K 0.04% 169
2025
Q1
$577K Buy
5,153
+351
+7% +$36.2K 0.05% 158
2024
Q4
$444K Sell
4,802
-361
-7% -$32.5K 0.03% 183
2024
Q3
$433K Sell
5,163
-1,596
-24% -$122K 0.03% 187
2024
Q2
$495K Hold
6,759
0.04% 175
2024
Q1
$495K Buy
6,759
+1
+0% +$77 0.04% 175
2023
Q4
$547K Buy
6,758
+1,771
+36% +$138K 0.04% 158
2023
Q3
$374K Buy
4,987
+239
+5% +$18.4K 0.03% 183
2023
Q2
$366K Buy
4,748
+105
+2% +$8.37K 0.03% 186
2023
Q1
$385K Buy
4,643
+46
+1% +$3.81K 0.03% 180
2022
Q4
$395K Buy
4,597
+558
+14% +$44.2K 0.04% 177
2022
Q3
$250K Hold
4,039
0.03% 171
2022
Q2
$250K Buy
4,039
+378
+10% +$23.4K 0.02% 204
2022
Q1
$217K Sell
3,661
-468
-11% -$29.9K 0.02% 196
2021
Q4
$300K Buy
+4,129
New +$284K 0.03% 171

Other funds holding GILD

Sonora Investment Management Group's GILD Position: Q3 2025 in Review

Sonora Investment Management Group held its Gilead Sciences (GILD) position steady in Q3 2025 at 4,531 shares worth $503K. The position accounts for 0.04% of the portfolio, ranked #164.

Sonora Investment Management Group first reported a position in GILD in Q4 2021 and has held it in 16 quarters since. The position peaked at $577K in Q1 2025. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Sonora Investment Management Group held 4,531 shares of Gilead Sciences worth $503K as of Q3 2025.
  • Sonora Investment Management Group left its Gilead Sciences share count unchanged in Q3 2025.
  • Gilead Sciences made up 0.04% of Sonora Investment Management Group's portfolio in Q3 2025, its #164 holding.
  • Sonora Investment Management Group first reported a position in Gilead Sciences in Q4 2021 and has held it in 16 quarters since.
  • Sonora Investment Management Group's Gilead Sciences position peaked at $577K in Q1 2025.
  • 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Sonora Investment Management Group's 13F filing for Q3 2025, filed 7 Oct 2025.